| |
|
|
|
Ocular Therapeutix- Inc.  
|
|
7.775 0.045 (0.01%) |
06-22 16:00 |
|
Open: |
7.74 |
Pre close: |
7.73 |
Target:
|
9.67
|
|
High: |
7.785 |
Low: |
7.4536 |
Resistance:
|
8.28
9.67
|
|
Volume: |
378,407 |
Market Cap: |
290M |
Support:
|
7.21
6.55
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.89
 |
MACD |
MACD(12,26):
|
0.32 |
|
MA(20): |
7.39  |
Signal(12,26,9): |
0.30 |
|
MA(100): |
6.39 |
Stochastic Oscillator |
%K(14,3):
|
72.19 |
|
MA(250): |
6.05 |
%D(3): |
77.11 |
|
Average Volume(K) |
3-Month: |
30644
|
52-Week |
High:
|
11.00 |
|
10-Days: |
52577 |
Low: |
3.30 |
|
RSI |
RSI(14):
|
63.01 |
Change(%): |
-22.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.020 |
Return on Equity (ttm) |
-99.3 |
Shares Out. (M) |
37.28 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-67.3 |
Shares Float (M) |
36.11 |
|
EPS Est. Next Year |
-2.110 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.530 |
Qtrly Rev. Growth |
-28.4 |
% Held by Institutions |
41.00 |
|
Forward EPS |
-1.381 |
Gross Profit (p.s.) |
0.020 |
Shares Short (K) |
4451 |
|
Book Value (p.s.) |
6.170 |
EBITDA (p.s.) |
-0.871 |
P/E |
-3.85 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.26 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-48.37 |
P/S |
4830866944.00 |
|
Operating Margin |
-3131.99 |
Levered Free Cash Flow
(M) |
-33.16 |
P/CF |
-5.99 |
|
|
|
|
|
|
